Company Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Equities
688192
CNE1000055W8
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.86 CNY | +6.41% |
|
+5.55% | -14.61% |
Business Summary
Number of employees: 581
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Drugs
100.0
%
| 0 | nan % | 91 | 100.0 % | - |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 0 | nan % | 91 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Xiao Lin Zhang
CEO | Chief Executive Officer | 60 | 17-10-26 |
Wei Wen Dong
CHM | Chairman | 38 | 18-05-31 |
Hong Bin Lu
DFI | Director of Finance/CFO | 46 | 20-06-30 |
Qing Bei Zeng
CTO | Chief Tech/Sci/R&D Officer | 62 | 17-11-30 |
Zhen Fan Yang
CTO | Chief Tech/Sci/R&D Officer | 56 | 17-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Lü
BRD | Director/Board Member | 56 | 17-09-30 |
Xue Gong Wang
BRD | Director/Board Member | 52 | 20-09-06 |
Guan Shan Zhu
BRD | Director/Board Member | 60 | 20-09-07 |
Xin Zhang
BRD | Director/Board Member | 52 | 20-09-07 |
Xiao Lin Zhang
CEO | Chief Executive Officer | 60 | 17-10-26 |
Director/Board Member | 51 | 17-09-30 | |
Hong Bin Lu
DFI | Director of Finance/CFO | 46 | 20-06-30 |
Bin Jiang
BRD | Director/Board Member | 60 | 20-09-07 |
Wei Wen Dong
CHM | Chairman | 38 | 18-05-31 |
- | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 415,653,120 | 82,131,680 ( 19.76 %) | 0 | 19.76 % |
Company contact information
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Building 4 199, 245 Liangjing Road
201203, Shanghai
+
http://www.dizalpharma.com![address Dizal (Jiangsu) Pharmaceutical Co., Ltd.(688192)](https://cdn.zonebourse.com/static/address/133577020.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.61% | 2.34B | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- 688192 Stock
- Company Dizal (Jiangsu) Pharmaceutical Co., Ltd.